| |
|
|
| |
 |
Tonalin XS-CLA
|
 |
|
| NSI Tonalin® XS-CLA is a clinically proven and patented conjugated linoleic acid (CLA) formula. CLA is a naturally occurring fatty acid, derived from safflower seeds (a p...<Read more> |
Compare
& Buy:
Tonalin XS-CLA
|
|
|
| Report Pricing & Page error |
 |
|
Tonalin XS-CLA Details
|
NSI Tonalin® XS-CLA is a clinically proven and patented conjugated linoleic acid (CLA) formula. CLA is a naturally occurring fatty acid, derived from safflower seeds (a premium dietary source of CLA). Studies have shown that CLA inhibits lipoprotein lipase, an enzyme that breaks down fat from our diet so that it can be absorbed and stored in the body. By suppressing this enzyme, CLA helps reduce the amount of fat deposited and stored throughout the body. Each NSI Tonalin XS-CLA softgel features clinically proven and stimulant-free Tonalin, containing 72-82% CLA, up to 35% higher than other brands. Tonalin XS-CLA helps to increase lean muscle, which burns more fat calories, resulting in natural slimming. In a trial published in a recent issue of the American Journal of Clinical Nutrition, Tonalin XS-CLA was shown to reduce body fat mass (BFM) in healthy, but overweight adults. Because you're reducing body fat, not water, the weight loss is more permanent and healthy. As evidenced by multiple studies published in Cancer Research, CLA is an effective antioxidant, shown to impart immune-boosting properties. Research also suggests that CLA may reduce the inflammation that occurs when the immune system is challenged. Various animal studies have shown that Tonalin XS-CLA may also offer benefits for arteriosclerosis by lowering both the LDL ("bad") and total cholesterol, along with the triglyceride counts.
|
|
 |
Special Offers: |
 |
|
|
|
|
 |
| Featured Brands |
|
| More
Featured Brands |
|
 |
|
 |
Top Selling Products:
Esberitox, Citicoline, Hydroxycut Hardcore, Cayenne, Sambucol Black Elderberry, Oregacyn, Candida Cleanse, Linseed Oil, 1250 mg, Trinovin - Prostate, Decabolen, Cetyl Myristoleate , |
|
 |
 |
 |
|
|
|
|
| |
|
|
|